Comparison of Five-year Survival and Disease-free Survival in Patients Diagnosed With Endometrium Cancer Who Underwent Total Laparoscopic Hysterectomy With and Without Uterine Manipulator

ConditionEndometrial Cancer

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexFemale

Age18-75

SponsorGaziosmanpasa Research and Education Hospital

About this trial

Comparison of five-year survival and disease-free survival in patients diagnosed with endometrium cancer who underwent total laparoscopic hysterectomy with and without a uterine manipulator

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

patients suitable for laparoscopic surgery patients ages 18-75 patients diagnosed figo stage 1 and 2 endometrial cancer

Disqualifiers

patients not suitable for laparoscopic surgery patients diagnosed figo stage 3 and 4 endometrial cancer pregnant patients

Trial population

Patients Diagnosed With Endometrium Cancer Who Underwent Total Laparoscopic Hysterectomy With and Without Uterine Manipulator

Trial design

Design model

Case-control

Time perspective

Prospective

Treatments tested in this trial

Patients Diagnosed With Endometrium Cancer Who Underwent Total Laparoscopic Hysterectomy With manipulator
Procedure/Surgery
patients who underwent laparoscopic hysterectomy with using uterine manipulator
lPatients Diagnosed With Endometrium Cancer Who Underwent Total Laparoscopic Hysterectomy without uterine manipulator
Procedure/Surgery
patients who underwent laparoscopic hysterectomy without using uterine manipulator

Treatment groups

108 Participants

are divided into 1 treatment group

Group A: patients diagnosed with endometrium cancer2 interventions

Trial outcomes

Primary outcomes

five year survival in patients diagnosed with endometrial cancer

Time frame

5 year

disease-free survival in patients diagnosed with endometrial cancer

Time frame

5 year

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Gaziosmanpasa Research and Education Hospital

Lead sponsor

Source ClinicalTrials.gov

Apply now